National Cancer Institute

Funding Opportunities

Sponsor Recent deadline Title Deadline 2 Deadline 3 FOA
National Cancer Institute (NCI) 10/28/2021 National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) –– –– RFA-CA-21-020
National Cancer Institute (NCI) 11/1/2021 Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) –– –– RFA-CA-21-042
National Cancer Institute (NCI) 11/1/2021 Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) –– –– RFA-CA-21-041
National Cancer Institute (NCI) 11/1/2021 NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) –– –– PAR-21-285
National Cancer Institute (NCI) 11/1/2021 NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) –– –– PAR-21-286
National Cancer Institute (NCI) 11/4/2021 Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) 11/3/2022 –– PAR-20-284
National Cancer Institute (NCI) 11/8/2021 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) –– –– PAR-19-198
National Cancer Institute (NCI) 11/8/2021 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) –– PAR-19-199
National Cancer Institute (NCI) 11/8/2021 Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) –– –– PAR-19-251
National Cancer Institute (NCI) 11/8/2021 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) 3/7/2022 11/8/2022 PAR-21-190

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.